Clinical Tool

Antidepressant Metabolic Guide

Medication education for patient-provider discussions.
Based on a 2025 Lancet systematic review and network meta-analysis.

Medication safety: This tool explains average findings from clinical trials. It cannot predict your individual response. Do not stop, start, or change an antidepressant without your prescriber.

How to read this tool

  • Numbers are trial averages, not predictions for one person.
  • The source analysis included 30 antidepressants; this tool highlights 17 commonly discussed agents.
  • Median treatment duration in the analysis was 8 weeks, so long-term effects may differ.
  • Confidence intervals matter. A neutral average does not mean no individual side effects.
  • This is not a medication-switching tool or a substitute for clinical care.

Source frame

What the analysis reviewed

Pillinger and colleagues reviewed antidepressant effects on weight, cardiovascular, metabolic, and other physiological parameters in a 2025 systematic review and network meta-analysis in The Lancet. The public tool uses selected summary values as medication-discussion prompts, not individual predictions.

Agents in source 30 antidepressants
Agents shown here 17 commonly discussed
Median duration 8 weeks

Class-level read before selecting a medication

These are broad patterns from trial averages. A prescriber still has to weigh diagnosis, response history, interactions, blood pressure, sleep, weight, liver history, and patient preference.

ClassExamples in this toolWhat to watch
SSRIsCitalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertralineOften weight-neutral in acute trials; individual appetite, sleep, sexual side effects, and liver signals still vary.
SNRIsDesvenlafaxine, duloxetine, levomilnacipran, venlafaxineBlood pressure, cholesterol, glucose, and liver-enzyme monitoring may matter depending on the agent and history.
Tricyclics / tetracyclicsAmitriptyline, nortriptyline, maprotilineWeight, heart rate, blood pressure, sedation, anticholinergic burden, and overdose safety need explicit discussion.
Atypical / multimodalAgomelatine, bupropion, mirtazapine, vortioxetineProfiles differ sharply by medication; weight, sleep, appetite, liver history, anxiety activation, and indication matter.
Important This tool provides statistical averages from clinical trials. Individual responses vary. Never change medication without consulting your prescriber.

Select a medication above

Choose an antidepressant to view its metabolic profile and monitoring discussion points.

Medication effects belong in the differential.

Metabolic effects are one part of the picture. Sleep, thyroid, iron, B12, inflammation, and medical history can matter too.